Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CEVOSTAMAB for Plasma cell myeloma refractory: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 7 adverse event reports in the FDA FAERS database where CEVOSTAMAB was used for Plasma cell myeloma refractory.

Most Reported Side Effects for CEVOSTAMAB

Side Effect Reports % Deaths Hosp.
Cytokine release syndrome 18 28.1% 4 15
Dyspnoea 7 10.9% 0 5
Bronchopulmonary aspergillosis 6 9.4% 0 4
Dizziness 6 9.4% 0 4
Drug interaction 6 9.4% 0 4
Nausea 6 9.4% 0 4
Plasma cell myeloma 6 9.4% 4 4
Pneumonia 6 9.4% 1 6
Pyrexia 6 9.4% 0 4
Febrile neutropenia 5 7.8% 0 4

Other Indications for CEVOSTAMAB

Plasma cell myeloma (52)

Other Drugs Used for Plasma cell myeloma refractory

DEXAMETHASONE (2,276) POMALIDOMIDE (1,562) LENALIDOMIDE (1,220) CARFILZOMIB (1,208) BORTEZOMIB (848) DARATUMUMAB (789) ISATUXIMAB (778) CYCLOPHOSPHAMIDE (518) IXAZOMIB (356) DOXORUBICIN (314)

Related Pages

CEVOSTAMAB Full Profile All Plasma cell myeloma refractory Drugs CEVOSTAMAB Demographics CEVOSTAMAB Timeline